共 50 条
- [21] The EU ETS: What We Know and What We Don't Know [J]. EMISSIONS TRADING AS A POLICY INSTRUMENT: EVALUATION AND PROSPECTS, 2015, : 25 - 42
- [22] BPMN Research: What We Know and What We Don't Know [J]. BUSINESS PROCESS MODEL AND NOTATION, BPMN 2012, 2012, 125 : 1 - 7
- [23] Vitamin A and preterm infants: what we know, what we don't know, and what we need to know [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2005, 90 (02): : 103 - 108
- [25] Anti-Vascular Endothelial Growth Factor Therapy in Pregnancy What We Know, What We Don't Know, and What We Don't Know We Don't Know [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1413 - 1417
- [26] First International Congress on Tracing of New Occupational Diseases ‘We (don’t) know what we don’t know’‘We (don’t) know what we don’t know’ [J]. TBV – Tijdschrift voor Bedrijfs- en Verzekeringsgeneeskunde, 2011, 19 (6): : 278 - 280
- [27] The Cost of Trading Transparency: What We Know, What We Don't Know, and How We Will Know [J]. JOURNAL OF PORTFOLIO MANAGEMENT, 2008, 35 (01): : 72 - +
- [29] What We Know - and What We Don't An Epilogue [J]. POLICIES AND POLITICS OF TEACHING RELIGION, 2ND EDITION, 2014, 16 : 153 - 155